RxDoctor Payments Data

Vrijendra Hoon, MD

Internal Medicine · Las Vegas, NVNPI 1619073897

Payments from drug & device makers

What this record shows

That places this record below the midpoint for internal medicine clinicians in NV, where the typical reported total is $253.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$1,811,923in research payments, 2019–2025

Across 173 payments — averaging $10,474 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$967K
  • Pfizer$258K
  • Lexicon Pharmaceuticals, Inc.$199K
  • Amgen$71K
  • Eli Lilly$55K
  • Acerus Pharmaceuticals Corporation$53K
  • plus $210K from 8 others

How this compares

$0 in reported general payments places this provider in the 5th percentile of 1,071 internal medicine providers in Nevada.

See all internal medicine providers in Nevada

Medicare billing

Part B allowed, 2024
$41,495
Medicare patients
236
Services billed
360

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lacosamide14$3,938
Baclofen15$228
Atorvastatin Calcium15$76
Amlodipine Besylate16$67
Clonidine Hcl13$58

Paid to pharmacies, not to this prescriber.

Other internal medicine in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →